BioSync
BioSync is developing a revolutionary predictive medicine technology focused on disease prevention. Their core offering is an implantable, self-sustaining graphene chip utilizing nanotechnology and miniaturized sensors to continuously monitor vital signs 24/7. This data is processed by personalized AI with machine learning to detect abnormal patterns and predict potential health crises before symptoms manifest. An accompanying personal health management app provides real-time data, proactive habit recommendations, and can alert healthcare professionals in emergencies. The technology aims to significantly reduce hospitalizations and costs associated with chronic and cardiovascular diseases by shifting the focus from reactive treatment to proactive prevention, thereby improving quality of life and global health outcomes.
BioSync
BioSync is developing a revolutionary predictive medicine technology focused on disease prevention. Their core offering is an implantable, self-sustaining graphene chip utilizing nanotechnology and miniaturized sensors to continuously monitor vital signs 24/7. This data is processed by personalized AI with machine learning to detect abnormal patterns and predict potential health crises before symptoms manifest. An accompanying personal health management app provides real-time data, proactive habit recommendations, and can alert healthcare professionals in emergencies. The technology aims to significantly reduce hospitalizations and costs associated with chronic and cardiovascular diseases by shifting the focus from reactive treatment to proactive prevention, thereby improving quality of life and global health outcomes.